Cyclacel Pharmaceuticals Inc
About Cyclacel Pharmaceuticals
Bio Green Med Solution, Inc. (NASDAQ: BGMS) is a Nasdaq-listed company that was formerly in the biopharmaceutical industry. As of September 2025 it shifted to fire safety protection and distribution. On September 12, 2025, it completed the acquisition of Fitters Sdn. Bhd., a Malaysia-based group specializing in fire protection products and services. Its revenue now comes from the sale and distribution of fire safety equipment in Malaysia, and its legacy biopharmaceutical operations are reported as discontinued. The company has entered into a Business Combination Agreement with Future NRG Sdn. Bhd., a Malaysian private limited company. The related Form S-4 was declared effective in October 2026, and a shareholder vote is planned for November 2026. BGMS also has outstanding 6% Convertible Exchangeable Preferred Stock, on which it pays quarterly cash dividends. Updated
Frequently Asked Questions
What does Cyclacel Pharmaceuticals do?
Bio Green Med Solution, Inc. (NASDAQ: BGMS) is a Nasdaq-listed company that was formerly in the biopharmaceutical industry. As of September 2025 it shifted to fire safety protection and distribution.